Fcγ receptor IIIb polymorphism and use of glucocorticoids at baseline are associated with infusion reactions to infliximab in patients with rheumatoid arthritis

OBJECTIVE: Infusion reaction is a major adverse event in patients with rheumatoid arthritis (RA) treated with infliximab. The possible factors including Fcγ receptor (FcγR) polymorphism associated with the development of infusion reactions in patients with RA receiving infliximab were prospectively...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Okuyama, Ayumi, Nagasawa, Hayato, Suzuki, Katsuya, Kameda, Hideto, Kondo, Harumi, Amano, Kouichi, Takeuchi, Tsutomu
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BMJ Group 2010
Onderwerpen:
Clinical and Epidemiological Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3015102/
https://ncbi.nlm.nih.gov/pubmed/20980704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2010.136283
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items